The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus
Open accessAbstract
Tat is an 86-amino acid protein involved in the replication of human immunodeficiency virus type 1 (HIV-1). Several studies have shown that exogenous Tat protein was able to translocate through the plasma membrane and to reach the nucleus to transactivate the viral genome. A region of the Tat protein centered on a cluster of basic amino acids has been assigned to this translocation activity. Recent data have demonstrated that chemical coupling of a Tat-derived peptide (extending from residues 37 to 72) to several proteins allowed their functional internalization into several cell lines or tissues. A part of this same domain can be folded in an alpha-helix structure with amphipathic characteristics. Such helical structures have been considered as key determinants for the uptake of several enveloped viruses by fusion or endocytosis. In the present study, we have delineated the main determinants required for Tat translocation within this sequence by synthesizing several peptides covering the Tat domain from residues 37 to 60. Unexpectedly, the domain extending from amino acid 37 to 47, which corresponds to the alpha-helix structure, is not required for cellular uptake and for nuclear translocation. Peptide internalization was assessed by direct labeling with fluorescein or by indirect immunofluorescence using a monoclonal antibody directed against the Tat basic cluster. Both approaches established that all peptides containing the basic domain are taken up by cells within less than 5 min at concentrations as low as 100 nM. In contrast, a peptide with a full alpha-helix but with a truncated basic amino acid cluster is not taken up by cells. The internalization process does not involve an endocytic pathway, as no inhibition of the uptake was observed at 4 degrees C. Similar observations have been reported for a basic amino acid-rich peptide derived from the Antennapedia homeodomain (1). Short peptides allowing efficient translocation through the plasma membrane could be useful vectors for the intracellular delivery of various non-permeant drugs including antisense oligonucleotides and peptides of pharmacological interest.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
The third helix of the Antennapedia homeodomain translocates through biological membranes.
Derossi, D., Joliot, A. H., Chassaing, G., & Prochiantz, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34080-2 · Cited by 2,034
Tat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism
Haystead, T. A. J., Sim, A. T. R., Carling, D., Honnor, R. C., Tsukitani, Y., Cohen, P., & Hardie, D. G. (1989) · Nature · doi:10.1038/337078a0 · Cited by 842
Potocytosis: Sequestration and Transport of Small Molecules by Caveolae
Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., & Lacey, S. W. (1992) · Science · doi:10.1126/science.1310359 · Cited by 735
Plank, C., Oberhauser, B., Mechtler, K., Koch, C., & Wagner, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99963-1 · Cited by 666
Wagner, E., Plank, C., Zatloukal, K., Cotten, M., & Birnstiel, M. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7934 · Cited by 658
Endocytosis and targeting of exogenous HIV-1 Tat protein.
Mann, D. A., & Frankel, A. D. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07697.x · Cited by 483
Structural and functional characterization of human immunodeficiency virus tat protein
Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W. A., & Rosen, C. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.1-8.1989 · Cited by 429
Cited by
Items 101–165 of 165
Layer‐By‐Layer‐Assembled Capsules and Films for Therapeutic Delivery
Becker, A. L., Johnston, A. P. R., & Caruso, F. (2010) · Small · doi:10.1002/smll.201000379 · Cited by 336
Caveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., & Beltram, F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00122-9 · Cited by 335
Mechanism Matters: A Taxonomy of Cell Penetrating Peptides
Kauffman, W. B., Fuselier, T., He, J., & Wimley, W. C. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.10.004 · Cited by 333
Acid-Active Cell-Penetrating Peptides for in Vivo Tumor-Targeted Drug Delivery
Jin, E., Zhang, B., Sun, X., Zhou, Z., Ma, X., Sun, Q., Tang, J., Shen, Y., Van Kirk, E., Murdoch, W. J., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311180x · Cited by 329
Structure, Expression, and Function of Human Pituitary Tumor-Transforming Gene (PTTG)
Zhang, X., Horwitz, G. A., Prezant, T. R., Valentini, A., Nakashima, M., Bronstein, M. D., & Melmed, S. K. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.156 · Cited by 324
Cell Penetrating Peptides in Drug Delivery
Snyder, E. L., & Dowdy, S. F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019289.61978.f5 · Cited by 323
Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
Martin, M. E., & Rice, K. G. (2007) · The AAPS Journal · doi:10.1208/aapsj0901003 · Cited by 319
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
MAE, M., & LANGEL, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.004 · Cited by 317
Cargo delivery kinetics of cell-penetrating peptides
Hällbrink, M., Florén, A., Elmquist, A., Pooga, M., Bartfai, T., & Langel, Ü. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00398-4 · Cited by 312
Efficient Intracellular Delivery of Nucleic Acid Pharmaceuticals Using Cell-Penetrating Peptides
Nakase, I., Akita, H., Kogure, K., Gräslund, A., Langel, Ü., Harashima, H., & Futaki, S. (2012) · Accounts of Chemical Research · doi:10.1021/ar200256e · Cited by 310
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Lättig-Tünnemann, G., Prinz, M., Hoffmann, D., Behlke, J., Palm-Apergi, C., Morano, I., Herce, H. D., & Cardoso, M. C. (2011) · Nature Communications · doi:10.1038/ncomms1459 · Cited by 308
Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cells
Thorén, P. E. G., Persson, D., Isakson, P., Goksör, M., Önfelt, A., & Nordén, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01135-5 · Cited by 303
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Cell surface adherence and endocytosis of protein transduction domains
Lundberg, M., Wikström, S., & Johansson, M. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00135-7 · Cited by 301
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Kim, B., Park, J., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201903637 · Cited by 298
Pharmacokinetics and Biodistribution of Novel Aptamer Compositions
Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C., & McCauley, T. G. (2004) · Pharmaceutical Research · doi:10.1007/s11095-004-7676-4 · Cited by 298
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
Borrelli, A., Tornesello, A., Tornesello, M., & Buonaguro, F. (2018) · Molecules · doi:10.3390/molecules23020295 · Cited by 295
Nanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 292
Direct and Rapid Cytosolic Delivery Using Cell-Penetrating Peptides Mediated by Pyrenebutyrate
Takeuchi, T., Kosuge, M., Tadokoro, A., Sugiura, Y., Nishi, M., Kawata, M., Sakai, N., Matile, S., & Futaki, S. (2006) · ACS Chemical Biology · doi:10.1021/cb600127m · Cited by 291
Cell-penetrating peptides: A comparative membrane toxicity study
Saar, K., Lindgren, M., Hansen, M., Eiríksdóttir, E., Jiang, Y., Rosenthal-Aizman, K., Sassian, M., & Langel, Ü. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.07.033 · Cited by 290
VE-Cadherin-Derived Cell-Penetrating Peptide, pVEC, with Carrier Functions
Elmquist, A., Lindgren, M., Bartfai, T., & Langel, Ü. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5316 · Cited by 290
Eguchi, A., Akuta, T., Okuyama, H., Senda, T., Yokoi, H., Inokuchi, H., Fujita, S., Hayakawa, T., Takeda, K., Hasegawa, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010625200 · Cited by 289
Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines
Tünnemann, G., Ter‐Avetisyan, G., Martin, R. M., Stöckl, M., Herrmann, A., & Cardoso, M. C. (2008) · Journal of Peptide Science · doi:10.1002/psc.968 · Cited by 286
In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein
Krosl, J., Austin, P., Beslu, N., Kroon, E., Humphries, R. K., & Sauvageau, G. (2003) · Nature Medicine · doi:10.1038/nm951 · Cited by 283
Lipid Bilayer Disruption by Polycationic Polymers: The Roles of Size and Chemical Functional Group
Mecke, A., Majoros, I. J., Patri, A. K., Baker, J. R., Banaszak Holl, M. M., & Orr, B. G. (2005) · Langmuir · doi:10.1021/la050629l · Cited by 283
Photodynamic therapy: Innovative approaches for antibacterial and anticancer treatments
Kolarikova, M., Hosikova, B., Dilenko, H., Barton‐Tomankova, K., Valkova, L., Bajgar, R., Malina, L., & Kolarova, H. (2023) · Medicinal Research Reviews · doi:10.1002/med.21935 · Cited by 282
Cell Membranes Open “Doors” for Cationic Nanoparticles/Biomolecules: Insights into Uptake Kinetics
Lin, J., & Alexander-Katz, A. (2013) · ACS Nano · doi:10.1021/nn4040553 · Cited by 280
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.006 · Cited by 280
A Stepwise Dissection of the Intracellular Fate of Cationic Cell-penetrating Peptides
Fischer, R., Köhler, K., Fotin-Mleczek, M., & Brock, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311461200 · Cited by 278
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders
Kabanov, A. V., & Gendelman, H. E. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.014 · Cited by 277
Futaki, S., & Nakase, I. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00221 · Cited by 277
Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes
Edgington, L. E., Berger, A. B., Blum, G., Albrow, V. E., Paulick, M. G., Lineberry, N., & Bogyo, M. (2009) · Nature Medicine · doi:10.1038/nm.1938 · Cited by 276
Rudolph, C., Plank, C., Lausier, J., Schillinger, U., Müller, R. H., & Rosenecker, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211891200 · Cited by 275
Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides
Meade, B. R., & Dowdy, S. F. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.004 · Cited by 274
Messenger proteins: homeoproteins, TAT and others
Prochiantz, A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00108-3 · Cited by 271
Fischer, R., Fotin‐Mleczek, M., Hufnagel, H., & Brock, R. (2005) · ChemBioChem · doi:10.1002/cbic.200500044 · Cited by 269
Han, S.-S., Li, Z.-Y., Zhu, J.-Y., Han, K., Zeng, Z.-Y., Hong, W., Li, W.-X., Jia, H.-Z., Liu, Y., Zhuo, R.-X., et al. (2015) · Small · doi:10.1002/smll.201402865 · Cited by 269
Astriab-Fisher, A., Sergueev, D., Fisher, M., Shaw, B. R., & Juliano, R. L. (2002) · Pharmaceutical Research · doi:10.1023/a:1016136328329 · Cited by 268
Silhol, M., Tyagi, M., Giacca, M., Lebleu, B., & Vivès, E. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02671.x · Cited by 268
Self-citationReissmann, S. (2014) · Journal of Peptide Science · doi:10.1002/psc.2672 · Cited by 266
Ziegler, A., Nervi, P., Dürrenberger, M., & Seelig, J. (2005) · Biochemistry · doi:10.1021/bi0491604 · Cited by 266
Taiariol, L., Chaix, C., Farre, C., & Moreau, E. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00484 · Cited by 265
Antimicrobial peptides with cell-penetrating peptide properties and vice versa
Splith, K., & Neundorf, I. (2011) · European Biophysics Journal · doi:10.1007/s00249-011-0682-7 · Cited by 265
Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study
El-Andaloussi, S., Järver, P., Johansson, H. J., & Langel, Ü. (2007) · Biochemical Journal · doi:10.1042/bj20070507 · Cited by 259
Cell-penetrating peptides transport therapeutics into cells
Ramsey, J. D., & Flynn, N. H. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.07.003 · Cited by 256
Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers
Patch, J. A., & Barron, A. E. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00385-x · Cited by 255
Ziegler, A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.005 · Cited by 255
Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape
Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242
Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier
Strazza, M., Pirrone, V., Wigdahl, B., & Nonnemacher, M. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.015 · Cited by 218
Identification and Rational Design of Novel Antimicrobial Peptides for Plant Protection
Marcos, J. F., Muñoz, A., Pérez-Payá, E., Misra, S., & López-García, B. (2008) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.121307.094843 · Cited by 205
Controlled pulmonary drug and gene delivery using polymeric nano-carriers
Beck-Broichsitter, M., Merkel, O. M., & Kissel, T. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.004 · Cited by 200
Nakase, I., Hirose, H., Tanaka, G., Tadokoro, A., Kobayashi, S., Takeuchi, T., & Futaki, S. (2009) · Molecular Therapy · doi:10.1038/mt.2009.192 · Cited by 118
Role of viral regulatory and accessory proteins in HIV-1 replication
Seelamgari, A. (2004) · Frontiers in Bioscience · doi:10.2741/1403 · Cited by 98
“Extracellular Tat was shown to enter cells mainly due to the presence of a cluster of basic amino acids, stimulating the transcriptional activity of the HIV-1 LTR and cellular genes (113, 114).”
BackgroundLa Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Gene Delivery Technologies with Applications in Microalgal Genetic Engineering
Gutiérrez, S., & Lauersen, K. J. (2021) · Biology · doi:10.3390/biology10040265 · Cited by 68
Peptide nucleic acids: versatile tools for gene therapy strategies
Dean, D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00087-9 · Cited by 61
A protein tertiary structure mimetic modulator of the Hippo signalling pathway
Adihou, H., Gopalakrishnan, R., Förster, T., Guéret, S. M., Gasper, R., Geschwindner, S., Carrillo García, C., Karatas, H., Pobbati, A. V., Vazquez‐Chantada, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19224-8 · Cited by 58
Kim, H., Seo, E.-H., Lee, S.-H., & Kim, B.-J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122054 · Cited by 48
Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
Fernandez Rico, C., Konate, K., Josse, E., Nargeot, J., Barrère-Lemaire, S., & Boisguérin, P. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.792885 · Cited by 45
Kuhne, C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg937 · Cited by 36
“We used the HIV-TAT protein transduction domain (11 amino acids, residues 47±57) (27) for protein import (reviewed in 28) of the class II restriction endonuclease PvuII into vertebrate cells.”
MethodGonçalves, E., Kitas, E., & Seelig, J. (2006) · Biochemistry · doi:10.1021/bi052221t · Cited by 28
Al-azzawi, S., & Masheta, D. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-00424-w · Cited by 28
Metadata
- Authors
- Vivès, E., Brodin, P., & Lebleu, B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-06
- Volume
- 272
- Issue
- 25
- Pages
- 16010-16017
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2042143995
- Cited by
- 2,373
- References
- 14
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.